PURPOSE: To investigate ocular dimensions in African Americans with the long anterior zonule (LAZ) trait. METHODS: A total of 61 African American LAZ subjects and 61 age-matched, race-matched, and sex-matched controls were compared with respect to central corneal thickness, central corneal curvature, axial length (AL), and subjective refraction. RESULTS: LAZ right eyes had a mean SR=+1.75±1.82 D and were 1.58 D (95% confidence interval, 0.83-2.31 D, P<0.0001) more hyperopic on average when compared with the control right eyes. LAZ right eyes also had an AL that was 0.69 mm (95% confidence interval, 0.34-1.04 mm, P<0.001) shorter on average than control right eyes. Similar results were found for left eyes. No differences were found with respect to central corneal curvature and central corneal thickness (P>0.05). CONCLUSIONS: In this data set, LAZ eyes tended to be more hyperopic and had ALs that were shorter than control eyes, characteristics that are consistent with elevated risk for angle-closure glaucoma.
PURPOSE: To investigate ocular dimensions in African Americans with the long anterior zonule (LAZ) trait. METHODS: A total of 61 African American LAZ subjects and 61 age-matched, race-matched, and sex-matched controls were compared with respect to central corneal thickness, central corneal curvature, axial length (AL), and subjective refraction. RESULTS: LAZ right eyes had a mean SR=+1.75±1.82 D and were 1.58 D (95% confidence interval, 0.83-2.31 D, P<0.0001) more hyperopic on average when compared with the control right eyes. LAZ right eyes also had an AL that was 0.69 mm (95% confidence interval, 0.34-1.04 mm, P<0.001) shorter on average than control right eyes. Similar results were found for left eyes. No differences were found with respect to central corneal curvature and central corneal thickness (P>0.05). CONCLUSIONS: In this data set, LAZ eyes tended to be more hyperopic and had ALs that were shorter than control eyes, characteristics that are consistent with elevated risk for angle-closure glaucoma.
Authors: Sayoko E Moroi; Kurt K Lark; Paul A Sieving; Kouros Nouri-Mahdavi; Ursula Schlötzer-Schrehardt; Gregory J Katz; Robert Ritch Journal: Am J Ophthalmol Date: 2003-12 Impact factor: 5.258
Authors: Daniel K Roberts; Yongyi Yang; Christina E Morettin; Tricia L Newman; Mary F Roberts; Jacob T Wilensky Journal: Anat Rec (Hoboken) Date: 2017-02-25 Impact factor: 2.064
Authors: Daniel K Roberts; Yongyi Yang; Christina E Morettin; Trinh Doan; Tricia L Newman; Jacob T Wilensky Journal: Clin Exp Ophthalmol Date: 2015-07-01 Impact factor: 4.207
Authors: Samuel Kyei; John Baptist Vianney Abowine; Ebenezer Zaabaar; Samuel Bert Boadi-Kusi; Frank Assiamah; Mohammed Abdul-Kabir; Kofi Asiedu Journal: Int Ophthalmol Date: 2022-01-27 Impact factor: 2.031
Authors: Brent Siesky; Alon Harris; Joseph Carr; Alice Verticchio Vercellin; Rehan M Hussain; Priyanka Parekh Hembree; Scott Wentz; Michael Isaacs; George Eckert; Nicholas A Moore Journal: J Glaucoma Date: 2016-09 Impact factor: 2.503
Authors: Daniel K Roberts; Bruce A Teitelbaum; David D Castells; Janis E Winters; Jacob T Wilensky Journal: J Glaucoma Date: 2016-01 Impact factor: 2.503
Authors: Daniel K Roberts; Tricia L Newman; Mary Flynn Roberts; Bruce A Teitelbaum; Janis E Winters Journal: Invest Ophthalmol Vis Sci Date: 2018-04-01 Impact factor: 4.799
Authors: Tricia L Newman; Daniel K Roberts; Christina E Morettin; Janice M McMahon; Mary Flynn Roberts Journal: Invest Ophthalmol Vis Sci Date: 2020-07-01 Impact factor: 4.799